May Hill Capital’s Novo Nordisk NVO Stock Holding History

May Hill Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,106	Closed	-$616K	–	232
2025 Q4	$616K	Buy	12,106 +3,702	+44%	+$189K	0.17%	88
2025 Q3	$466K	Sell	8,404 -279	-3%	-$16.3K	0.14%	107
2025 Q2	$599K	Sell	8,683 -70	-0.8%	-$4.76K	0.2%	83
2025 Q1	$608K	Buy	8,753 +3,883	+80%	+$321K	0.23%	69
2024 Q4	$419K	Buy	+4,870	New	+$527K	0.16%	83

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

May Hill Capital's NVO Position: Q1 2026 in Review

May Hill Capital sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 12,106 shares — an estimated $616K sold.

May Hill Capital first reported a position in NVO in Q4 2024 and held it in 5 quarters. The position peaked at $616K in Q4 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

May Hill Capital reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
May Hill Capital sold 12,106 Novo Nordisk shares in Q1 2026, an estimated $616K.
May Hill Capital first reported a position in Novo Nordisk in Q4 2024 and held it in 5 quarters.
May Hill Capital's Novo Nordisk position peaked at $616K in Q4 2025.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.